DUBLIN, April 12, 2022 /PRNewswire/ --The "Brain Tumor Drugs Global Market Opportunities And Strategies To 2030, By Drugs, End User" report has been added to ResearchAndMarkets.com's offering.
The global brain tumor drugs market reached a value of nearly $5,656.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.5% since 2015. The market is expected to grow from $5,656.4 million in 2020 to $9,128.1 million in 2025 at a rate of 10%. The market is then expected to grow at a CAGR of 8.8% from 2025 and reach $13,932 million in 2030.
Growth in the historic period in the brain tumor drugs market resulted increasing prevalence of neurological disorders, increased healthcare expenditure, increased number of approvals for oncology (cancer) drugs, increase in pharmaceutical R&D expenditure, and advances in cancer drug discovery. The market was restrained increasing use of targeted therapies, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.
Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs, and revised FDA regulations to facilitate biologics drug development. Factors that could hinder the growth of the market in the future include high costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, and coronavirus pandemic.
The brain tumor drugs market is segmented by drugs into temozolomide, bevacizumab, and others. The others was the largest segment of the brain tumor drugs market segmented by drugs, accounting for 69.3% of the total in 2020. Going forward, the Temozolomide segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by drugs, at a CAGR of 15.2% during 2020-2025.
The brain tumor drugs market is also segmented by end-user into hospital pharmacies, retail pharmacies and other end-users. The hospital pharmacies market was the largest segment of the brain tumor drugs market segmented by end-user, accounting for 53.4% of the total in 2020. Going forward, the other end-users segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by end-user, at a CAGR of 11.1% during 2020-2025.
Asia Pacific was the largest region in the brain tumor drugs market, accounting for 31.8% of the total in 2020. It was followed by the North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the brain tumor drugs market will be Asia Pacific and Western Europe where growth will be at CAGRs of 11.8% and 9.9% respectively during 2020-2025. These will be followed by South America and North America, where the markets are expected to register CAGRs of 9.4% and 9.1% respectively during 2020-2025.
The global brain tumor drugs market is fragmented, with a large number of players. The top ten competitors in the market made up to 28.1% of the total market in 2020. Major players in the market include F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Pfizer Inc., and Merck & Co. Inc.
The top opportunities in the brain tumor drugs market segmented by drugs will arise in the others segment, which will gain $2,494.7 million of global annual sales by 2025. The top opportunities in the brain tumor drugs market segmented by end-user will arise in hospital pharmacies segment, which will gain $1,804.9 million of global annual sales by 2025.
Market-trend-based strategies for the brain tumor drugs includes investing in combination of drugs for brain tumor treatment, adapting the use of phase zero clinical trials to improve efficacy, use of technology for drug delivery that improves the efficacy of the drug, focus on the expansion of cell and gene therapy, and carrying out strategic mergers and acquisitions.
Player-adopted strategies in the brain tumor drugs market include focusing on new product development, strategic collaborations, expanding business presence in developed and emerging regions, strategic acquisitions and agreements, and strengthening their product portfolio by new drug approvals.
To take advantage of the opportunities, the publisher recommends the brain tumor companies to focus on combination of drugs to help with treatment, adopt phase zero clinical trials, focus on nanotechnology for drug delivery and tumor treatment, focus on expansion of cell and gene therapy & CAR-T for brain tumors, expanding in emerging markets, set up authorized distributors and sales representatives, bundled payments, skimmed pricing, adopt premium pricing, participate in trade shows and events, increase visibility through business websites and listing websites, use big data analytics to improve marketing activities, targeting hospitals and pharmacies to spread awareness, and targeting the geriatric population.
Key Topics Covered:
1. Brain Tumor Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction6.1. Segmentation By Geography
7. Brain Tumor Drugs Market Characteristics7.1. Market Definition7.2. Market Segmentation By Drugs7.2.1. Temozolomide7.2.2. Bevacizumab7.2.3. Others7.3. Market Segmentation By End-User7.3.1. Hospital Pharmacies7.3.2. Retail Pharmacies/Drug Stores7.3.3. Other Pharmacies
8. Brain Tumor Drugs Market Trends And Strategies8.1. Combination Of Drugs To Help With Treatment8.2. Adapting Phase Zero Clinical Trials8.3. Nanotechnology For Drug Delivery And Tumor Treatment8.4. Expansion Of Cell And Gene Therapy & CAR-T For Brain Tumors8.5. Increasing Mergers And Acquisitions
9. Impact Of COVID-19 On Brain Tumor Drugs Market9.1. Clinical Trial Delays9.2. Low Usage Of Drugs9.3. Supply Chain Issues9.4. Shortage In Resources9.5. Impact on Patients9.6. Future Outlook
10. Global Brain Tumor Drugs Market Size And Growth10.1. Market Size10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)10.2.1. Drivers Of The Market 2015 - 202010.2.2. Restraints On The Market 2015 - 202010.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)10.3.1. Drivers Of The Market 2020 - 202510.3.2. Restraints On The Market 2020 - 2025
11. Global Brain Tumor Drugs Market Segmentation11.1. Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)11.2. Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12. Brain Tumor Drugs Market, Regional And Country Analysis12.1. Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)12.2. Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/dtbkxg
Media Contact:
Research and MarketsLaura Wood, Senior Manager[emailprotected]
For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Read more here:
- Electronic Materials Company Cambrios Announces Closing $14.5 Million Round - November 8th, 2009 [November 8th, 2009]
- Europe's 'Extreme light infrastructure' project gears up for launch - November 8th, 2009 [November 8th, 2009]
- Industrial nanotechnology processes getting closer - November 8th, 2009 [November 8th, 2009]
- Konsultation zum Austria Nano-Aktionsplan - November 8th, 2009 [November 8th, 2009]
- Bewegungen von Viren auf Membranen live verfolgen - November 8th, 2009 [November 8th, 2009]
- Thailand Nanotechnology Conference on health, energy, environment - November 8th, 2009 [November 8th, 2009]
- Samsung Intensifies Advanced Foundry Logic Process Development with New Semiconductor Research Center - November 8th, 2009 [November 8th, 2009]
- Infineon and TSMC to Jointly Develop 65nm Embedded Flash Process Technology For Automotive and Chip Card Applications - November 8th, 2009 [November 8th, 2009]
- Abraxis Health Dedicates State of the Art Nanotechnology and Biologics Facility in Phoenix, Arizona - November 8th, 2009 [November 8th, 2009]
- Beneq Announces The First Continous Mode Atomic Layer Deposition Research Tool - November 8th, 2009 [November 8th, 2009]
- An electron microscope with glasses - November 8th, 2009 [November 8th, 2009]
- Give your opinion on the Nanotechnology Research Code of Conduct - November 8th, 2009 [November 8th, 2009]
- Presentations from the OECD Conference on the Potential Environmental Benefits of Nanotechnology - November 8th, 2009 [November 8th, 2009]
- DFI Nanotechnology Expands Into China With Strategic Alliance in Hong Kong - November 8th, 2009 [November 8th, 2009]
- Pre-announcement: Call for proposals within 'Energy Efficiency with Nanotechnology' - November 8th, 2009 [November 8th, 2009]
- This week in nanotechnology - November 8th, 2009 [November 8th, 2009]
- New funding for development and deployment of UAlbany nanofabrication strategies - November 8th, 2009 [November 8th, 2009]
- Applied Materials Acquires the Assets of Advent Solar - November 8th, 2009 [November 8th, 2009]
- Advanced Researcher Grant 2009 an Nanowissenschaftlerin Luisa de Cola - November 8th, 2009 [November 8th, 2009]
- Ocean Optics Launches Dedicated OEM Website - November 8th, 2009 [November 8th, 2009]
- New synthetic molecules trigger immune response to HIV and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Computer predicts reactions between molecules and surfaces, with 'chemical precision' - November 8th, 2009 [November 8th, 2009]
- Austria showcases its nanotechnology initiative - November 8th, 2009 [November 8th, 2009]
- Nanocapsules for artificial photosynthesis - November 8th, 2009 [November 8th, 2009]
- Work begins on laboratory for world's strongest microscope - November 8th, 2009 [November 8th, 2009]
- New cancer detection method with fluorescent silica beads - November 8th, 2009 [November 8th, 2009]
- Die Magnetisierung einzelner Atome manipulieren - November 8th, 2009 [November 8th, 2009]
- Novel nanoparticles could become a safer alternative to gene therapy delivered by viruses - November 8th, 2009 [November 8th, 2009]
- DOE awards Argonne, partners more than $7 million for solar energy-related research projects - November 8th, 2009 [November 8th, 2009]
- Magnetic nanoparticles to simultaneously diagnose, monitor and treat - November 8th, 2009 [November 8th, 2009]
- Study of ultracold atoms proves theory about universal quantum mechanism - December 13th, 2009 [December 13th, 2009]
- RUSNANO Supervisory Council approves nanostructured non-metallic coatings project - December 13th, 2009 [December 13th, 2009]
- Julian Wess Award for outstanding achievements in elementary particle and astroparticle physics - December 13th, 2009 [December 13th, 2009]
- New Pegasus300 Sold to Leading French Research Institute for CMOS Packaging - December 13th, 2009 [December 13th, 2009]
- Soitec Expands Into the Fast Growing Solar Energy Market With the Acquisition of Concentrix Solar - December 13th, 2009 [December 13th, 2009]
- Students send microbe nanobiotechnology experiment on Space Shuttle Atlantis - December 13th, 2009 [December 13th, 2009]
- Photovoltaic cells to power biological nanorobots inside the body - December 13th, 2009 [December 13th, 2009]
- Environmental and human health impacts of nanotechnology - December 13th, 2009 [December 13th, 2009]
- Elusive 'hot' electrons captured in ultra-thin solar cells - December 13th, 2009 [December 13th, 2009]
- Light-generating transistors to power labs on chips - December 13th, 2009 [December 13th, 2009]
- Combining rare-earth clusters with traditional metal catalysts reveals secrets of chemical transformation - December 13th, 2009 [December 13th, 2009]
- Hexagon Expands Its Offering in the Vision Metrology Business - December 13th, 2009 [December 13th, 2009]
- Azaya Therapeutics Receives FDA Authorization to Start Phase I Cancer Trial - December 13th, 2009 [December 13th, 2009]
- Researchers engineer bacteria to turn carbon dioxide into liquid fuel - December 13th, 2009 [December 13th, 2009]
- Argonne creates green home for world-class nanotechnology research - December 13th, 2009 [December 13th, 2009]
- The mechanism behind superinsulation may lead to new types of electronics - December 13th, 2009 [December 13th, 2009]
- Biosensors change color when they detect specific neural messages - December 14th, 2009 [December 14th, 2009]
- First measurement of cancer biomarkers in whole blood - December 14th, 2009 [December 14th, 2009]
- Nanoprobes hit targets in tumors, could lessen chemo side effects - December 14th, 2009 [December 14th, 2009]
- EYP/energy group joins UAlbany NanoCollege's National Institute for Sustainable Energy - December 14th, 2009 [December 14th, 2009]
- Scientists isolate new antifreeze molecule in Alaska beetle - December 14th, 2009 [December 14th, 2009]
- Ocean Optics XR-Series Spectrometers Cover 200-1050 nm Wavelengths - December 14th, 2009 [December 14th, 2009]
- All-in-one cancer-killing nanoparticle can be tracked in real time with MRI - December 14th, 2009 [December 14th, 2009]
- Nanobodies modifizieren die Form und Funktion von Proteinen - December 14th, 2009 [December 14th, 2009]
- Elias A. Zerhouni, M.D. to Join Leica Microsystems' Parent Company Board of Directors - December 14th, 2009 [December 14th, 2009]
- France to invest billions in nanotechnology - December 14th, 2009 [December 14th, 2009]
- AlphaRx Appoints President for its China Operations - December 14th, 2009 [December 14th, 2009]
- Vistec Enters Into Electron-Beam Lithograpy Project With Moscow University - December 14th, 2009 [December 14th, 2009]
- Record-breaking ultrasensitive spectrometer identifies trace gases in real time - December 14th, 2009 [December 14th, 2009]
- NanoMech Receives Navy Contract to Develop Nanotechnology Lubricant - December 14th, 2009 [December 14th, 2009]
- Heart cells display a behavior-guiding 'nanosense' on new lab-on-a-chip - December 14th, 2009 [December 14th, 2009]
- New curriculum mixes nanotechnology and skiing - December 14th, 2009 [December 14th, 2009]
- Rexahn and TheraTarget Form Nanotechnology Research Collaboration - December 14th, 2009 [December 14th, 2009]
- Unidym Enters Agreement to Integrate Carbon Nanotube Films Into LCDs - December 14th, 2009 [December 14th, 2009]
- Carl Zeiss Meditec Closes Financial Year on a High - December 14th, 2009 [December 14th, 2009]
- The Scott Partnership Appointed to Launch Innovative New Printed Electronics Business - December 14th, 2009 [December 14th, 2009]
- New Centre for Molecular Epidemiology to put bacteria on the world map - December 14th, 2009 [December 14th, 2009]
- New nanotechnology association established to address 21st century natural resource and energy security challenges - December 14th, 2009 [December 14th, 2009]
- Analysis of information gathering initiatives on manufactured nanomaterials - December 14th, 2009 [December 14th, 2009]
- OECD publishes manufactured nanomaterials roadmap 2010 - December 14th, 2009 [December 14th, 2009]
- New imaging technique allows quick evaluation of graphene sheets - December 14th, 2009 [December 14th, 2009]
- National Institute of Standards and Technology invests up to $71 million in new manufacturing, infrastructure research and development - December 16th, 2009 [December 16th, 2009]
- Southwest Nanotechnologies Recieves Two Prestigious Research Grants To Deveop A New Generation of Carbon Nanotubes - December 16th, 2009 [December 16th, 2009]
- Nanolithographic technique allows multiple chemicals on a single chip - December 16th, 2009 [December 16th, 2009]
- Study documents puzzling movement of electricity-producing bacteria near energy sources - December 16th, 2009 [December 16th, 2009]
- Erstmals Daten aus lebenden Zellen: Optisches Verfahren misst molekulare Reaktionszeiten - December 16th, 2009 [December 16th, 2009]
- New Constant Diameter NeedleProbes with Unique Ability to Measure Liquid Surface Properties by AFM - December 16th, 2009 [December 16th, 2009]
- Chemical Nanotechnology Talks X: Green nano - challenges of sustainability - December 16th, 2009 [December 16th, 2009]
- Patents Issued for Licensed PAL-M Super-resolution Technology - December 16th, 2009 [December 16th, 2009]
- International Network CONTACT researches the use of carbon nanotubes in various applications - December 16th, 2009 [December 16th, 2009]